“Building Better Vaccines for a Viral World”
Speaker: Anthony Griffiths, PhD, Professor at 91㽶Ƶ - Columbia, Director of the Laboratory for Infectious Disease Research
Date: Febuary 20, 2025, noon-1 p.m.
Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room
*Zoom option available
Registration opening soon
About the Speaker
Anthony Griffiths, PhD, is a professor in the Department of Molecular Microbiology and Immunology, investigator in the Bond Life Sciences Center, and director of the Laboratory for Infectious Disease Research (LIDR). He has dedicated his career to working with viruses, which form the basis of his research program.
Dr. Griffiths studied herpes simplex virus as a graduate student at Cambridge University and as a post-doc at Harvard Medical School. He established his own group at Texas Biomedical Research Institute in San Antonio, where he broadened his interest to viruses that require high (BSL-3) and maximum (BSL-4) containment. Much of this work focused on Ebola virus but also included other viruses. From there, Dr. Griffiths moved to the National Emerging Infectious Diseases Laboratories at Boston University to continue the work in high and maximum containment, adding coronaviruses to the research program.
The group has a goal to understand fundamental virological processes to aid the development of vaccines and therapeutics. The LIDR works with a range of viruses utilizing molecular techniques and animal models for infectious disease research to facilitate this work.
About the Discovery Series
provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
For questions about this event or any others in the Discovery Series, please reach out to Mackenzie Lynch.
Reviewed 2024-10-31